SCHEMBL24832965

SCHEMBL24832965

Cc1ccc(C2CCC(=O)NC2=O)cn1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.60
▸ DDB1 Q16531 18/20 0.60
▸ POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25074184 0.82 CRBN (0.57) CRBNDDB1POLB
SCHEMBL25501664 0.82 CRBN (0.57) CRBNDDB1POLB
SCHEMBL29990479 0.82 CRBN (0.60) CRBNDDB1POLB
SCHEMBL30778437 0.82 CRBN (0.69) CRBNDDB1POLB
SCHEMBL30066434 0.82 CRBN (0.60) CRBNDDB1POLB
SCHEMBL25074524 0.82 CRBN (0.60) CRBNDDB1POLB
SCHEMBL25074141 0.82 CRBN (0.60) CRBNDDB1POLB
SCHEMBL24670590 0.82 CRBN (0.60) CRBNDDB1POLB
SCHEMBL25501627 0.82 CRBN (0.69) CRBNDDB1POLB
SCHEMBL25500434 0.82 CRBN (0.60) CRBNDDB1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112692-A1 CASITAS B-LINEAGE LYMPHOMA PROTOONCOGENE B (CBL-B) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2024-05-30 — — WO disclosed
WO-2023116934-A1 KRASG12D PROTEIN HYDROLYSIS REGULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州泽璟生物制药股份有限公司 2023-06-29 — — WO disclosed
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 — — WO disclosed
WO-2023274390-A1 BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF 杭州和正医药有限公司 2023-01-05 — — WO disclosed
Send feedback